A study of knowledge attitude practices and identification of perceived barriers towards screening for diabetic retinopathy amongst diabetics in an industrial area in western Maharashtra
DOI:
https://doi.org/10.15584/ejcem.2023.3.20Keywords:
awareness, barriers to diabetic retinopathy screening, diabetic retinopathy screening, knowledgeAbstract
Introduction and aim. Diabetic retinopathy (DR) screening is first step in prevention of diabetic retinopathy related ocular morbidity. The aim of the study was to assess the gaps in the knowledge and awareness and evaluate its effects on the attitude and practice in known diabetic patients and to assess any anticipated barriers and its association with knowledge, attitude and practices.
Material and methods. A closed-ended questionnaire was given to 112 diabetics who met the inclusion criteria and visited a tertiary eye hospital in western Maharashtra. The purpose of the questionnaire was to assess knowledge, attitude and practices and perceived barriers to the study of DR. The statistical analysis was done on SPSS software.
Results. In our study, 73.4% did not know about DR, suggesting poor awareness about the disease, 59.5% did not feel the need for regular eye checkup. 67 (61.1%) had no knowledge about blood sugar control level and lipid control for effective control of DR, 89 (79.5%) of participants did not know about effective treatment options. Moreover, 74 (66.1%) participants were advised for DR screening by physician, while 60 (53.5%) were willing to get screened, negative attitude was not getting screened when vision is good seen in 87 (79.1%) participants. Furthermore, 84 (75%) patient think eye checkup are expensive, 66% people believe availability of doctor is an issue. 60 (54.5%) think that eye checkups are time consuming.
Conclusion. Our study demonstrated, that Spearman’s correlation coefficient between knowledge and awareness and based on attitude and practice, is 0.54, and that this is statistically significant (p<0.01). Our study has shown poor awareness and knowledge about the disease thus affecting attitude and practices, eye screening is considered expensive has been pointed out a major barrier in this study.
Downloads
References
Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. doi: 10.1016/j.diabres.2019.107843
Patil S, Gogate P, Vora S, et al. Prevalence, causes of blindness, visual impairment and cataract surgical services in Sindhudurg district on the western coastal strip of India. Indian J Ophthalmol. 2014;62(2):240-245. doi: 10.4103/0301-4738.128633
Ramachandran A, Jali MV, Mohan V, Snehalatha C, Viswanathan M. High prevalence of diabetes in an urban population in south India. BMJ. 1988;297(6648):587-590. doi: 10.1136/bmj.297.6648.587
Murthy GV, Gupta SK, Bachani D, Jose R, John N. Current estimates of blindness in India. Br J Ophthalmol. 2005;89(3):257-260. doi: 10.1136/bjo.2004.056937
Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group. Ophthalmology. 1981;88(7):583-600.
Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98(5):766-785.
Mohan D, Raj D, Shanthirani CS, et al. Awareness and knowledge of diabetes in Chennai--the Chennai Urban Rural Epidemiology Study [CURES-9]. J Assoc Physicians India. 2005;53:283-287.
Graham-Rowe E, Lorencatto F, Lawrenson JG, et al. Barriers and enablers to diabetic retinopathy screening attendance: Protocol for a systematic review. Syst Rev. 2016;5(1):134. doi: 10.1186/s13643-016-0309-2
Khandekar R, Harby SA, Harthy HA, Lawatti JA. Knowledge, attitude and practice regarding eye complications and care among Omani persons with diabetes - A cross sectional study. Oman J Ophthalmol. 2010;3(2):60-65. doi: 10.4103/0974-620X.64228
Singh T, Sharma S, Nagesh S. Socio-economic status scales updated for 2017, international Research in medical sciences. Int J Res Med Sci. 2017;5(7):3264-3267.
Mahesh G, Elias A, Sandhya N, et al. Chengamanad Diabetic Retinopathy Awareness Study (CDRAS). Kerala Journal of Ophthalmology. 2006;28:14-21.
World Health Organization. https://www.who.int/cholera/vaccines/kap_protocol.pdf. Accessed 12 February, 2023.
Javitt JC, Aiello LP, Chiang Y, Ferris FL, Canner JK, Greenfield S. Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for health-care reform. Diabetes Care. 1994;17(8):909-917. doi: 10.2337/diacare.17.8.909
Srinivasan NK, John D, Rebekah G, et al. Diabetes and Diabetic Retinopathy: Knowledge, Attitude, Practice (KAP) among Diabetic Patients in A Tertiary Eye Care Centre. J Clin Diagn Res. 2017;11(7):NC01-NC07. doi: 10.7860/JCDR/2017/27027.10174
Babu N, Kim, Ramchandani B, et al. Diabetes and Diabetic Retinopathy: Knowledge, Attitude, Practice (KAP) Among Paramedical Personnel (PMPS) and Community Members (CMS) In Southern India. AIOC Proceedings. 2009:150-153.
Namperumalsamy P, Kim R, Vignesh TP, et al. Prevalence and risk factors for diabetic retinopathy: a population-based assessment from Theni District, south India. Br J Ophthalmol. 2009;93(4):429-434. doi: 10.1136/bjo.2008.147934
Kumar S, Kumar G, Velu S, et al. Patient and provider perspectives on barriers to screening for diabetic retinopathy: an exploratory study from southern India. BMJ Open. 2020;10(12):e037277. doi: 10.1136/bmjopen-2020-037277
Graham-Rowe E, Lorencatto F, Lawrenson JG, et al. Barriers to and enablers of diabetic retinopathy screening attendance: a systematic review of published and grey literature. Diabet Med. 2018;35(10):1308-1319. doi: 10.1111/dme.13686
Lin KY, Hsih WH, Lin YB, Wen CY, Chang TJ. Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy. J Diabetes Investig. 2021;12(8):1322-1325. doi: 10.1111/jdi.13480
Tan TE, Wong TY. Diabetic retinopathy: Looking forward to 2030. Front Endocrinol (Lausanne). 2023;13:1077669. doi: 10.3389/fendo.2022.1077669
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
